- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04868435
Triggers for Post-Viral Parosmia (ParosmiaQ)
Triggers for Post-Viral Parosmia After COVID-19 and Non-COVID-19 Infections
Background: Many people lose their sense of smell after they have had a cold, flu or sinus infection. Recovery (if at all) generally starts with a "parosmia" phase which means every-day smells become distorted and over-poweringly objectionable, and this can lead to malnutrition and depression. We do not know much about how or why parosmia happens, but there are key foods common to those who suffer from parosmia which seem to trigger the distortion.
Parosmia and COVID-19 Loss of smell has recently been recognised as an official symptom of COVID-19, and we are starting to get reports of people who have recently had COVID-19 developing parosmia. The triggers seem to be similar to those of the common cold, flu or virus infections, but the journey between loss of smell and parosmia is different.
Hypotheses
- Triggers of distortion will be the same for all parosmics.
- There may be additional trigger foods in different cultures.
Questions
- What are the trigger foods and beverages for parosmia?
- Are there regional/cultural variations?
- Does Covid-19 parosmia differ from "standard" post-viral parosmia?
The overall aim of the project is to understand the mechanisms involved in parosmia. The approach is to identify foods and everyday aromas associated with parosmia and to determine whether they are the same across different continents/cultures/ethnic backgrounds, and whether Covid-19 parosmia is any different to non-Covid-19 parosmia. The questionnaire will ask about Covid-19 status, ethnic background, smell loss and parosmia, and the changes that occurred between smell loss and parosmia. The participants will then answer questions on up to 15 everyday smells, some of which our preliminary evidence shows are common triggers, and others which are not. The questionnaire will be globally distributed, for example through current collaborations in the UK, US, Germany, Iran, China, Japan and Brazil. It will be completed by participants who are currently experiencing parosmia.
All participants will be asked to record any foods that they find distorted and provide a list of aromas which returned undistorted.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Reading, United Kingdom, RG6 6AP
- University of Reading
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Individuals should be currently experiencing parosmia
Exclusion Criteria:
- Individuals below 18 years old will be excluded from the study
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire
Time Frame: 20 minutes
|
Outcomes from the questionnaire will be: List of major trigger foods for anosmia. Typical descriptions for smell distortions. Severity of parosmia. Patterns of anosmia/parosmia symptoms in post-viral infections including Covid-19. |
20 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jane K Parker, PhD, University of Reading
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UoR SREC 29/2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parosmia
-
Stanford UniversityRecruiting
-
University of NottinghamTasteTechCompletedAnosmia | Dysgeusia | Ageusia | Parosmia | PhantosmiaUnited Kingdom
-
Johns Hopkins UniversityCompletedAnesthesia | PediatricsUnited States
-
Lawson Health Research InstituteRecruiting
-
Washington University School of MedicineCompleted
-
Washington University School of MedicineWithdrawnCOVID-19 | Olfactory Disorder | ParosmiaUnited States
-
Menoufia UniversityNot yet recruiting
-
Washington University School of MedicineCompletedCOVID-19 | Anosmia | Olfactory Disorder | Parosmia | HyposmiaUnited States
-
Universidad PanamericanaCompletedCOVID-19 | Anosmia | Hyposmia | Smell Loss | ParaosmiaMexico
-
Université du Québec à Trois-RivièresRecruitingCOVID-19 | Anosmia | SARS-CoV-2 Infection | Parosmia | HyposmiaCanada